Enovis Corporation Common Stock (ENOV)

About ENOV

Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments. The Prevention and Recovery segment offers rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular therapy systems and compression garments, electr…

Sector

Health Care

Industry

Industrial Specialties

Employees

7,802

Website

www.enovis.com/

Fundamentals

1-day range

$24.79$25.38

Market cap

$1.51B

P/E (trailing)

—

P/E (forward)

6.20

EPS (trailing)

$-19.27

Dividend yield

—

Beta

1.46

Avg. volume

1.14M

Forecasts

12 analyst ratings

Enovis Corporation Common Stock Competitors

Chosen by industry and closest market cap.

• ENOV

  Enovis Corporation Common Stock

  $24.92

  ▲ 0.36%
  Market cap $1.51BP/E —
  $19.14$34.28
• TRS

  TriMas Corporation Common Stock

  $39.49

  ▼ 0.23%
  Market cap $1.45BP/E 1.71
  $30.43$45.43
• WLFC

  Willis Lease Finance Corporation Common Stock

  $53.28

  ▼ 3.32%
  Market cap $1.35BP/E 14.44
  $38$81.54
• ADSE

  ADS-TEC ENERGY PLC Ordinary Shares

  $11.38

  ▲ 0.71%
  Market cap $879.02MP/E —
  $7.89$13.5
• ESTA

  Establishment Labs Holdings Inc. Common Shares

  $70.63

  ▼ 1.64%
  Market cap $2.33BP/E —
  $36.53$97.59
• MEC

  Mayville Engineering Company Inc. Common Stock

  $19.25

  ▼ 5.36%
  Market cap $508.87MP/E —
  $12.25$38.76
• OFLX

  Omega Flex Inc. Common Stock

  $26.94

  ▲ 0.43%
  Market cap $312.42MP/E 22.77
  $25.58$37.92

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Enovis Corporation: Arvis Is Disrupting The Health Care Industry
  SeekingAlpha · 8/21/2026
• Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man's Land
  SeekingAlpha · 8/20/2026
• Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $45
  benzinga · 8/17/2026
• Canaccord Genuity Maintains Buy on Enovis, Lowers Price Target to $45
  Benzinga · 8/17/2026
• Enovis Q2 Earnings Call Highlights
  Yahoo · 8/8/2026
• Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $39
  Benzinga · 8/7/2026
• Enovis Corporation 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/7/2026
• Enovis Corporation (ENOV) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• Enovis Corp (ENOV) (Q2 2026) Earnings Call Highlights: Strong Innovation Drives 5% Organic ...
  Yahoo · 8/6/2026

• Christine Ortiz · June 30, 2026 · Grant

  846
• Oliver Engert · June 15, 2026 · Buy

  1.0K @ $20.92
• Oliver Engert · June 11, 2026 · Grant

  1.0K @ $20.99
• Oliver Engert · June 11, 2026 · Buy

  1.0K @ $21.75
• Oliver Engert · June 11, 2026 · Buy

  200 @ $20.99
• Oliver Engert · June 10, 2026 · Buy

  1.0K @ $23
• Oliver Engert · June 1, 2026 · Buy

  1.0K @ $22.22
• Brady Shirley · May 19, 2026 · Grant

  9.3K
• Barbara W. Bodem · May 19, 2026 · Grant

  9.3K
• Philip Okala · May 19, 2026 · Grant

  9.3K
• Christine Ortiz · May 19, 2026 · Grant

  9.3K
• Liam Kelly · May 19, 2026 · Grant

  9.3K
• Rajiv Vinnakota · May 19, 2026 · Grant

  9.3K
• Sharon L. Wienbar · May 19, 2026 · Grant

  9.3K
• Angela S. Lalor · May 19, 2026 · Grant

  9.3K

Institutional Ownership

March 31, 2026

Total shares held

65.10M

Total value held

$1.45B

Institutional holders

247